Literature DB >> 26898408

Propensity of salicylamide and ethenzamide cocrystallization with aromatic carboxylic acids.

Maciej Przybyłek1, Dorota Ziółkowska2, Karina Mroczyńska3, Piotr Cysewski4.   

Abstract

The cocrystallization of salicylamide (2-hydroxybenzamide, SMD) and ethenzamide (2-ethoxybenzamide, EMD) with aromatic carboxylic acids was examined both experimentally and theoretically. The supramolecular synthesis taking advantage of the droplet evaporative crystallization (DEC) technique was combined with powder diffraction and vibrational spectroscopy as the analytical tools. This led to identification of eleven new cocrystals including pharmaceutically relevant coformers such as mono- and dihydroxybenzoic acids. The cocrystallization abilities of SMD and EMD with aromatic carboxylic acids were found to be unexpectedly divers despite high formal similarities of these two benzamides and ability of the R2,2(8) heterosynthon formation. The source of diversities of the cocrystallization landscapes is the difference in the stabilization of possible conformers by adopting alternative intramolecular hydrogen boding patterns. The stronger intramolecular hydrogen bonding the weaker affinity toward intermolecular complexation potential. The substituent effects on R2,2(8) heterosynthon properties are also discussed.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  2,4-Dihydroxybenzoic acid (PubChem CID: 1491); 2,6-Dihydroxybenzoic acid (PubChem CID: 9338); 3,4-Dihydroxybenzoic acid (PubChem CID: 72); 4-Acetamidobenzoic acid (PubChem CID: 19266); 4-Hydroxybenzoic acid (PubChem CID: 135); Acetylsalicylic acid (PubChem CID: 2244); Aromatic carboxylic acids; Benzoic acid (PubChem CID: 243); Ethenzamide; Ethenzamide (PubChem CID: 3282); Miscibility; Pharmaceutical cocrystals; Salicylamide; Salicylamide (PubChem CID: 5147); Salicylic acid (PubChem CID: 338)

Mesh:

Substances:

Year:  2016        PMID: 26898408     DOI: 10.1016/j.ejps.2016.02.010

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  4 in total

1.  2-Ethoxybenzamide stimulates melanin synthesis in B16F1 melanoma cells via the CREB signaling pathway.

Authors:  Kazuomi Sato; Ryosuke Ando; Honoka Kobayashi; Takashi Nishio
Journal:  Mol Cell Biochem       Date:  2016-09-16       Impact factor: 3.396

2.  New Screening Protocol for Effective Green Solvents Selection of Benzamide, Salicylamide and Ethenzamide.

Authors:  Maciej Przybyłek; Anna Miernicka; Mateusz Nowak; Piotr Cysewski
Journal:  Molecules       Date:  2022-05-22       Impact factor: 4.927

3.  In silico screening of dicarboxylic acids for cocrystallization with phenylpiperazine derivatives based on both cocrystallization propensity and solubility advantage.

Authors:  Piotr Cysewski
Journal:  J Mol Model       Date:  2017-03-27       Impact factor: 1.810

4.  Pharmaceutical Cocrystals of Ethenzamide: Molecular Structure Analysis Based on Vibrational Spectra and DFT Calculations.

Authors:  Mei Wan; Jiyuan Fang; Jiadan Xue; Jianjun Liu; Jianyuan Qin; Zhi Hong; Jiusheng Li; Yong Du
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.